FABP1 had not been reported to be related to CD4+ T cells, but it could affect the function of tumor-associated macrophages by participating in tumor internal metabolic pathways, and thereby exerting anti-tumor effects (Xu et al., 2020). The gene discussed is CD4; the disease is neoplasm.